mRNA cancer vaccines market projected to reach $61.52 billion in 2024
Summary: Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) - A new report shows the mRNA cancer vaccines and therapeutics market is expected to grow from $52.85 billion in 2023 to $61.52 billion in 2024, with a compound annual growth rate of 16.4%.
The report highlights factors driving this growth, including promising clinical trial results and increased acceptance of mRNA technology. It also notes a shift towards personalized medicine and advancements in mRNA delivery systems.
Notably, WestGene Biopharma received FDA approval for an mRNA cancer vaccine in May 2024, marking a significant development in treating certain cancers. North America remains the largest market, while Asia Pacific is projected to grow the fastest.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.
Read more about how I calculate significance, or see today's top ranked news on the main page:
See today's news rankings